Universal-Beteiligungs- und Servicegesellschaft’s Axsome Therapeutics AXSM Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.6M	Sell	63,551 -7,174	-10%	-$1.56M	0.02%	488
2026 Q1	$12M	Buy	70,725 +1,867	+3%	+$322K	0.02%	552
2025 Q4	$12.6M	Buy	68,858 +956	+1%	+$133K	0.02%	526
2025 Q3	$8.25M	Buy	67,902 +15,934	+31%	+$1.79M	0.01%	662
2025 Q2	$5.42M	Buy	51,968 +1,872	+4%	+$198K	0.01%	799
2025 Q1	$5.84M	Buy	+50,096	New	+$5.71M	0.01%	751

Other funds holding AXSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's AXSM Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Axsome Therapeutics (AXSM) stake by 10% in Q2 2026, selling an estimated $1.56M and leaving 63,551 shares worth $15.6M. The position accounts for 0.02% of the portfolio, ranked #488.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in AXSM in Q1 2025 and has held it in 6 quarters since. 285 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

Universal-Beteiligungs- und Servicegesellschaft held 63,551 shares of Axsome Therapeutics worth $15.6M as of Q2 2026.
Universal-Beteiligungs- und Servicegesellschaft sold 7,174 Axsome Therapeutics shares in Q2 2026, an estimated $1.56M.
Axsome Therapeutics made up 0.02% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #488 holding.
Universal-Beteiligungs- und Servicegesellschaft first reported a position in Axsome Therapeutics in Q1 2025 and has held it in 6 quarters since.
285 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.